ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,22
-1,51%
Dow Jones
42 732,13
0,80%
DAX
19 906,08
-0,49%
Brent Oil
76,495
0,00%
Bitcoin
97 892,90
-0,22%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. IsoPlexis Corporation (ISO)

  7. IsoPlexis Corporation (ISO) Actualités

ISO

IsoPlexis (ISO)

IsoPlexis Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ISO
DateHeureSourceTitreSymboleSociété
15/06/202322h18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ISOIsoPlexis Corporation
31/03/202314h33Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ISOIsoPlexis Corporation
22/03/202313h14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ISOIsoPlexis Corporation
21/03/202321h53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ISOIsoPlexis Corporation
21/03/202314h11Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ISOIsoPlexis Corporation
21/03/202313h02PR Newswire (US)Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology CompanyNASDAQ:ISOIsoPlexis Corporation
16/03/202322h29Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:ISOIsoPlexis Corporation
09/03/202322h34Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ISOIsoPlexis Corporation
02/03/202314h16Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ISOIsoPlexis Corporation
14/02/202322h54Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ISOIsoPlexis Corporation
12/01/202322h05GlobeNewswire Inc.IsoPlexis Reports Preliminary Full Year 2022 RevenueNASDAQ:ISOIsoPlexis Corporation
22/12/202200h52Dow Jones NewsStocks to Watch: IsoPlexis, Lexicon Pharma, Micron Tech, Berkeley LightsNASDAQ:ISOIsoPlexis Corporation
21/12/202222h49GlobeNewswire Inc.Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology CompanyNASDAQ:ISOIsoPlexis Corporation
11/11/202213h35TipRanksSVB Securities Sticks to Their Hold Rating for IsoPlexis (ISO)NASDAQ:ISOIsoPlexis Corporation
10/11/202222h12Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ISOIsoPlexis Corporation
10/11/202213h00GlobeNewswire Inc.IsoPlexis Reports Third Quarter 2022 Financial ResultsNASDAQ:ISOIsoPlexis Corporation
09/11/202213h00GlobeNewswire Inc.IsoPlexis to Participate in Upcoming Investor ConferencesNASDAQ:ISOIsoPlexis Corporation
19/10/202213h00GlobeNewswire Inc.IsoPlexis to Report Third Quarter 2022 Financial Results on November 10, 2022NASDAQ:ISOIsoPlexis Corporation
13/09/202213h00GlobeNewswire Inc.IsoPlexis Announces First APAC Publication, Illustrating Early Impact of Codeplex PlatformNASDAQ:ISOIsoPlexis Corporation
06/09/202213h00GlobeNewswire Inc.IsoPlexis Partners with MediMergent and The Center for Cancer and Blood Disorders in Study of AZD7442 for Prevention of COVID-19 Infection in Immuno-Compromised Cancer PatientsNASDAQ:ISOIsoPlexis Corporation
31/08/202213h00GlobeNewswire Inc.IsoPlexis to Participate in the Morgan Stanley Global Healthcare ConferenceNASDAQ:ISOIsoPlexis Corporation
24/08/202215h17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ISOIsoPlexis Corporation
23/08/202213h00GlobeNewswire Inc.IsoPlexis Announces the Appointment of former Luminex Corporation Chairman and CEO, Nachum “Homi” Shamir to its Board of DirectorsNASDAQ:ISOIsoPlexis Corporation
10/08/202213h00GlobeNewswire Inc.IsoPlexis Reports Second Quarter 2022 Financial ResultsNASDAQ:ISOIsoPlexis Corporation
21/07/202213h00GlobeNewswire Inc.IsoPlexis to Report Second Quarter 2022 Financial Results on August 10, 2022NASDAQ:ISOIsoPlexis Corporation
31/05/202214h32Edgar (US Regulatory)Specialized Disclosure Report (sd)NASDAQ:ISOIsoPlexis Corporation
15/05/202216h30TipRanksMorgan Stanley Thinks IsoPlexis’ Stock is Going to RecoverNASDAQ:ISOIsoPlexis Corporation
11/05/202213h00GlobeNewswire Inc.IsoPlexis Reports First Quarter 2022 Financial ResultsNASDAQ:ISOIsoPlexis Corporation
29/04/202217h40Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:ISOIsoPlexis Corporation
27/04/202222h04Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ISOIsoPlexis Corporation
 Showing the most relevant articles for your search:NASDAQ:ISO

Dernières Valeurs Consultées

EU
VIV
Vivendi
NASDAQ
AMZN
Amazon.com
EU
PX1
CAC 40
EU
PX4
SBF 120
EU
CAP
Capgemini
COIN
DOGEUSD
Dogecoin
COIN
ETHUSD
Ethereum
EU
ACA
Credit Agricole
COIN
XRPUSD
Ripple
NASDAQ
AAPL
Apple
EU
RNO
Renault
EU
GLE
Societe Generale
EU
DG
Vinci
COIN
AVAXUSD
Avalanche
EU
BEL20
Bel 20
EU
EN
Bouygues
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés